SunBio,Inc. (KOSDAQ:067370)
South Korea · Delayed Price · Currency is KRW 6,960.00
0.00 (0.00%)
At close: Jul 18, 2025, 3:30 PM KST
SunBio,Inc. Company Description
SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide.
Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage.
The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee.
Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives.
The company was founded in 1997 and is headquartered in Gunpo-si, South Korea.
SunBio,Inc.
| Country | South Korea |
| Founded | 1997 |
| Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: 95, Sanbon-ro Gunpo-si, 15849 South Korea | |
| Phone | 82 3 1423 5467 |
| Website | sunbio.com |
Stock Details
| Ticker Symbol | 067370 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |